Financhill
Back

TransMedics Group Quote, Financials, Valuation and Earnings

TransMedics Group Price Quote

$76.08
+0.04 (+-4.11%)
(Updated: November 23, 2024 at 5:57 AM ET)

TransMedics Group Key Stats

Sell
41
TransMedics Group (TMDX) is a Sell

Day range:
$72.68 - $76.87
52-week range:
$67.77 - $177.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.55
P/B ratio:
12.16%

Volume:
2.6M
Avg. volume:
2M
1-year change:
10.28%
Market cap:
$2.6B
Revenue:
$241.6M
EPS:
$0.94

How Much Does TransMedics Group Make?

Is TransMedics Group Growing As A Company?

  • What Is TransMedics Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.64%
  • What Is TransMedics Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TransMedics Group Stock Price Performance

  • Did TransMedics Group Stock Go Up Last Month?
    TransMedics Group share price went down by -38.15% last month
  • Did TMDX's Share Price Rise Over The Last Year?
    TMDX share price rose by 10.28% over the past 1 year

What Is TransMedics Group 52-Week High & Low?

TransMedics Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TransMedics Group?

  • How Much Debt Does TransMedics Group Have?
    Total long term debt quarterly is $508.5M
  • How Much Cash Does TransMedics Group Have?
    Cash and short term investments quarterly total is $330.1M
  • What Is TransMedics Group’s Book Value Per Share?
    Book value per share is 6.25

Is TransMedics Group Cash Flow Positive?

  • What Is TMDX Cash Flow From Operations?
    Cash flow from operations (TTM) is $37.4M
  • What Is TransMedics Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $22.6M
  • What Is TransMedics Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$157.5M

TransMedics Group Return On Invested Capital

  • Is Management Doing A Good Job?
    TMDX return on invested capital is 4.86%
  • What Is TransMedics Group Return On Assets?
    ROA measures how assets are converting to revenues and is 4.46%
  • What Is TMDX Return On Equity?
    ROE is a measure of profitability and is 19.83%

TransMedics Group Earnings Date & Stock Price

TransMedics Group Competitors

TransMedics Group Dividend Yield

TransMedics Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -62.31%
Revenue: 63.72% -5.42%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 123.88
Upside from Last Price: 62.91%

Major Shareholders

  • How many TMDX shares are owned by institutional investors?
    59.8M TMDX shares are owned by institutional investors
  • How many TMDX shares are owned by insiders?
    469K TMDX shares are owned by insiders